Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2003
11/27/2003US20030221207 Cardiac-specific 11beta hydroxysteroid dehydrogenase type 2 transgenic mice
11/27/2003US20030221206 Using in vitro fertilization to produce gentically engineered animals for use as models for prevention and treatment of disease
11/27/2003US20030221205 Olfactory and pheromones G-protein coupled receptors
11/27/2003US20030221203 High efficiency regulatable gene expression system
11/27/2003US20030221199 Surfactant protein D for the prevention and diagnosis of pulmonary emphysema
11/27/2003US20030220491 Novel human transporter proteins and polynucleotides encoding the same
11/27/2003US20030220490 Cell membrane directed drugs
11/27/2003US20030220489 29 human secreted proteins
11/27/2003US20030220484 Modified ciliary neurotrophic factors
11/27/2003US20030220483 Comprises fibroblast growth factor homologous factor- 1 (FHF-1) for disgnosing, prevention and treatment of neurodegenerative or neoplastic disorders
11/27/2003US20030220480 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
11/27/2003US20030220478 Novel compounds
11/27/2003US20030220473 An antitumor agent of polynucleotide sequence, a vector, a genetic construct, for encoding a protein
11/27/2003US20030220472 Treatment of hematopoietic cell deficiencies, stimulating the production of hematopoietic cells, recombinant DNA sequence encodes or vector expression of the muteins; side effect reduction
11/27/2003US20030220405 DNA encoding an epsilon, epsilon-lycopene cyclase from romaine lettuce
11/27/2003US20030220306 Transcripts harboring inton 1, or fragment thereof; preventing or treating Alzheimer's Disease; ameliorating a neurodegenerative condition; modulating amyloid precursor protein; selectively inhibiting COX-3 or PCOX-1a activity
11/27/2003US20030220289 Compositions for delivering nucleic acids to cells
11/27/2003US20030220288 Nor-1 and nur77 nuclear receptors as targets for anti-leukemia therapy
11/27/2003US20030220287 Inhibit expression of anthrax toxin receptor mRNA and human tumor endothelial marker 8
11/27/2003US20030220286 Undetectable biological effect in the absence of an inducer, but which exhibits efficient inducibility in the presence of an inducer.
11/27/2003US20030220285 Expression vectors for stimulating an immune response and methods of using the same
11/27/2003US20030220282 Antisense modulation of PTP1B expression
11/27/2003US20030220279 Decreasing cell proliferation by decreasing levels of PP5
11/27/2003US20030220277 Methylation of plasmid vectors
11/27/2003US20030220275 Antisense modulation of kinesin-like 1 expression
11/27/2003US20030220273 Antisense modulation of phosphodiesterase 4D expression
11/27/2003US20030220256 Truncated 24kDa basic fibroblast growth factor
11/27/2003US20030220248 Use of MP52 or MP121 for the treatment and prevention of diseases of the nervous system
11/27/2003US20030220239 Epitope sequences
11/27/2003US20030220238 BFIT compositions and methods of use
11/27/2003US20030220232 Peptide with the sequence Gln-Tyr-Asn-Ala-Asp and derivatives differing from the original sequence by the addition, substitution, inversion, insertin, deletion or modification of one or more amino acids; sodium ion channel binder
11/27/2003US20030220229 Modulate an immunological response by T cells of Type I diabetics which can be used as an indicator; derived from a region of proinsulin that spans the junction between the B chain and C peptide; inhibiting the development/progression
11/27/2003US20030219910 Immunoassay method/equipment, biological component measurable toilet, anti-albumin monoclonal antibody, cell strain producing the same, and albumin detection kit
11/27/2003US20030219902 Methods and vectors for facilitating site-specific recombination
11/27/2003US20030219901 Temperature sensitive mutant derivatives of the broad host range plasmid pBHR1
11/27/2003US20030219900 Method and marker for simple transformation and selection of recombinant protists
11/27/2003US20030219899 Mosaic adenoviral vectors
11/27/2003US20030219897 A vector for transfecting a plant cell, obtained from a tomato mosaic virus, a tobacco masaic virus, producing an antisense RNA or a suppressor RNA, for inhibiting or reducing of gene expression
11/27/2003US20030219894 Induction of insulin-producing cells
11/27/2003US20030219892 Illuminating the cells to obtain an image, determining the locations of specific individual cells, using energy beam to induce a response; detection, for drug delivery of genes into specific cells of interest
11/27/2003US20030219891 An biological, optic apparatus for gene testing, optical sensor comprising pixels for detecting chemiluminescence between the reaction of biological sample and a reagent
11/27/2003US20030219888 Binding enzyme, toxin with inorganic catalyst or fusion proteins which are contained in achromobacter cells, for using diagnositic, therapeutic, and drug screening
11/27/2003US20030219886 Directed evolution of novel binding proteins
11/27/2003US20030219885 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/27/2003US20030219882 Isolating glutamic acid from genetically engineered enterobacter culture for use in animal feeds, cosmetics and food processing
11/27/2003US20030219881 Coryneform bacteria which produce chemical compounds I
11/27/2003US20030219878 Using restriction independent cloning events (RICE) to prepare and ligate novel RNA sequences
11/27/2003US20030219876 Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell
11/27/2003US20030219875 Albumin fusion proteins
11/27/2003US20030219874 Comprises endothelial differentiation gene receptor proteins (EDG8) for monitoring receptivity to and/or diagnosing cancer, angiogenesis and inflammation
11/27/2003US20030219873 Self-assembling recombinant papillomavirus capsid proteins
11/27/2003US20030219870 Secretion of proteins with multiple disulfide bonds in bacteria and uses thereof
11/27/2003US20030219869 Expression of recombinant human proteins in Tetrahymena
11/27/2003US20030219868 Comprises nucleotide sequences coding g-protein coupled receptor for diagnosing and/or treating behavioral or physiological disorders; drug screening
11/27/2003US20030219864 Novel variants of RANKL protein
11/27/2003US20030219860 Comprises nucleotide sequences coding novel tumor necrosis factor receptor (TRAIN-R) for treating inflammatory bowel disease and arthritic condition; antiinflammatory agents
11/27/2003US20030219859 Preparing viral protein 22 (VP22) for use as gene therapeutic tool in treatment of cancer; drug delivery
11/27/2003US20030219858 Novel heteromultimeric ion channel receptor and uses thereof
11/27/2003US20030219855 Comprises genetically engineered transcription factor for identifying elements associated neuronal differentiation/determination
11/27/2003US20030219834 Identifying modulator of cold sensation and pain; drug screening; cancer diagnosis
11/27/2003US20030219829 Heavy chain libraries
11/27/2003US20030219826 Comprises amino acid sequence for treating arthritic, inflammatory and apoptosis disorders; mimetics
11/27/2003US20030219819 Method for improving efficiencies in livestock production
11/27/2003US20030219811 Comprises nucleotide sequences for diagnosing tuberculosis infection and mycobacterial infections
11/27/2003US20030219804 Anchored strand displacement amplification on an electronically addressable microchip
11/27/2003US20030219798 Comprises nucleotide sequences coding enzymes associated with ubiquinone biosynthesis; drug and cosmetic preparation
11/27/2003US20030219792 Using recombinase-polymerase amplification to propagate target DNA without the use of thermocycling or thermophilic enzymes
11/27/2003US20030219791 Transducer of MAS signalling
11/27/2003US20030219789 36P6D5: secreted tumor antigen
11/27/2003US20030219779 Transposon mediated multiplex sequencing
11/27/2003US20030219773 Using restriction independent cloning events (RICE) to generate recombinant nucleotide sequences
11/27/2003US20030219768 Lung cancer therapeutics and diagnostics
11/27/2003US20030219764 Using mathematical models associated with mutational analysis to observe, determine and detect genes associated with preferential metabolic pathways
11/27/2003US20030219763 Plant protoplast gene expression systems and uses thereof
11/27/2003US20030219762 Using microarrays to remove uncapped nucleotide sequences and thereby enriching for capped messenger rna
11/27/2003US20030219752 Preparing immunoglobulin library; high throughput assay; immunoassays; immunotherapeutics and/or diagnostics; anticarcinogenic agents
11/27/2003US20030219750 Schizophrenia associated genes, proteins and biallelic markers
11/27/2003US20030219746 Comprises oligonucleotide sequence for diagnosing and prognosing cancer
11/27/2003US20030219742 Antisense modulation of HMGI-C expression
11/27/2003US20030219741 Novel full-length cDNA
11/27/2003US20030219740 DNA sequences isolated from human colonic epithelial cells
11/27/2003US20030219739 Comprises muscle protein for treating and preventing of muscle atrophy
11/27/2003US20030219736 Using DNA microarrays to analyze and identify patterns of bacterial gene expression and transcriptional changes throughout genome
11/27/2003US20030219735 Genetically engineered adeno-associated viral vector comprising single stranded heterologous nucleotide sequence for use as tool diagnostic tool in gene therapy and genomic screening
11/27/2003US20030219733 Antibody gene transfer and recombinant AAV therefor
11/27/2003US20030219732 Adaptation sites of porcine reproductive and respiratory syndrome virus
11/27/2003US20030219730 Comprises nucleotide sequences associated with small round structured viruses (SRSVs) for use as diagnostic tool in detecting food poisoning; hygienic testing
11/27/2003US20030219728 Comprises nucleotide sequences coding HIV-associated life preserver (HALP) protein for treating apoptosis disorders; viricides; antiapoptosis; genetic vaccines
11/27/2003US20030219726 Detection of abnormalities leading to cervical malignancy
11/27/2003US20030219723 Bioassys for identifying hepatitis C viricidal agents; drug screening
11/27/2003US20030219722 Comprises preparation of novel binding prolypeptides via mutagenesis, expression, chromatographic selection and amplification; drug screening
11/27/2003US20030219714 Apparatus for identifying and characterizing toxic compounds; drug screening; side effect reduction
11/27/2003US20030219511 Carboxypeptidase of cocoa
11/27/2003US20030219474 A polynucleotide that hybridizes to a Bcl-2-encoding polynucleotide and a lipid associated with such polynuclotide
11/27/2003US20030219466 For bone/tooth engineering and repair; bone morphogenic proteins; stents; kits
11/27/2003US20030219458 Multivalent vaccination using recombinant adenovirus
11/27/2003US20030219452 HIV envelope V3-CCR5 binding site immunogen
11/27/2003US20030219450 Tat/rev/vpr/nef genes/proteins for vaccines
11/27/2003US20030219449 Glycoproteins for screening animals; vaccines; gene therapy kits
11/27/2003US20030219448 Peptide epitope-based vaccine for treating herpes simplex virus infections and related diseases
1 ... 2366 2367 2368 2369 2370 2371 2372 2373 2374 2375 2376 2377 2378 2379 2380 2381 2382 2383 2384 2385 2386 ... 4023